en
E-mail us
(925) 558-5040
bd_global@crystalpharmatech.com
 cn
cn
Clinical and Commercial Manufacturing
Scalable Global CDMO Solutions

Crystal Pharmatech is a premier partner for high-quality clinical and commercial production. We leverage robust formulation platforms to accelerate drug launches.

Oral Solid Dosage

Expert production of tablets, capsules, and sachets.

Bioavailability Enhancement

Specialized spray drying and HME manufacturing.

Pediatric Innovation

Advanced manufacturing of mini-tablets.

Suzhou, China

50,590 sq. ft.
GMP Manufacturing
  • 17,250 sq. ft. Batches up to 120 kg
  • 21,500 sq. ft. Clinical Supply Depot
R&D Headquarters 2026
  • Doubled Capacity: Relocating in 2026
  • Pre-formulation to Production train

2026 Expansion: Commercial Readiness

Large-Scale ASDPSD-3 spray dryer.
Equipment>1,000L blenders, WP200, Korsh XL400.
Market-ReadyBlister packaging solutions.

Toronto, Canada

12,500 sq. ft.
GMP Facility
  • Supporting batches up to 100 kg
R&D Space
  • 3,500 sq. ft. for agile development
Quality Excellence

Audit Milestones

NMPA

Certified

Achieved Dec 2022.
EU QP

Audit Passed

Completed Dec 2023.
FDA

Expected 2H 2026

Triggered by US manufacture.
SGS

Inspected

3Q2023 - 3Q2025.

31

Global Audits

06

U.S. Audits

Verified Jan 2026

Achieve Your Success with Our Expertise

Have a question or need support with your project? Please complete the form, and our team will get back to you shortly.




Our capabilities span three specialized platforms:

  • Small Molecule

  • Crystal Bio Solutions

  • Crystal NAX


By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your inquiry. The information you submit will be governed by our Privacy Policy.

Related Resources
Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability
News
Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability
27 Mar 2023
Crystal Formulation Services' GMP Manufacturing Facility Successfully Passes the Remote Audit by US Client, Marking a Key Milestone for Its International Expansion
News
Crystal Formulation Services' GMP Manufacturing Facility Successfully Passes the Remote Audit by US Client, Marking a Key Milestone for Its International Expansion
12 May 2023
Small Molecule
First-Time-Right 3-STEP Approach Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Analytical Research and Quality Control Formulation Development Clinical and Commercial GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Crystal NAX
DNA Synthesis RNA Synthesis LNP Formulation Services Analytical & Characterization Services Early-Phase Manufacturing Catalogue Products
Platforms
Solid Form Screening Solid Form Developability Evaluation Absolute Structure Determination Crystallization Process Development Conventional Oral Solid Dosage Forms Bioavailability Enhancement for Insoluble Compounds & PROTAC & Oral Peptides Mini-tablet
Quick Links
Highlights News Events Knowledge Hub Webinar Series
Contact Us
bd_global@crystalpharmatech.com (925) 558-5040
U.S
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China 215123

Floor 1, Bldg. 3, 68 Chunpu Road, Suzhou Industrial Park, Suzhou, China 215123
Subscribe to be the first to get the updates!

Subscribe to be the first to get the updates!

Privacy Policy
Sitemap
Small Molecule
First-Time-Right 3-STEP Approach Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Analytical Research and Quality Control Formulation Development Clinical and Commercial GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Platforms
Quick Links
About Us Events
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
bd_global@crystalpharmatech.com (925) 558-5040
Privacy Policy
Sitemap